Design, Preparation, and Ex Vivo Skin Permeation of Doxepin Microemulsion System for Topical Delivery
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.16786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Hossein Heidari Kaydan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. Hauptthemen laut MEDLINE: Skin Absorption, Doxepin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Doxepin (DX) is used orally to relieve itching but can cause side effects like blurred vision, dry mouth, and drowsiness due to its antimuscarinic effect. To reduce these adverse effects and improve skin permeation, DX is being developed in topical formulations. This study aims to improve DX skin absorption by developing a microemulsion (ME) formulation (ME‐DX). Method and Materials ME formulations containing 5% DX were prepared using the phase diagram method with a mixture of essential oil (oleic acid), surfactant (Tween 80 and Labrazol), and cosurfactant (propylene glycol or PG). The physicochemical properties of these formulations were assessed to improve the topical application of DX.
Results
ME droplet sizes ranged from 9.8 to 61.6 nm, with viscosities between 114 and 239 cps. Studies showed a significant correlation between DX release percentages and viscosity. ME‐DX‐2 released 46.51% of the drug after 24 h. Selected ME‐DX formulations demonstrated Weibull, Log Wagner, and zero‐order release kinetics, and improved skin permeability. ME‐DX‐8 exhibited an eightfold increase in J ss and P parameters compared to the control group. MEs maintained 99.9% of DX after 6 months without color changes or phase separation, indicating long‐term stability.
Conclusion
This research demonstrates that altering the content and composition of MEs can change the physicochemical properties and permeability characteristics of DX when introduced into rats. Additionally, ME formulation shows promise as an effective vehicle for topical DX delivery in atopic dermatitis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Nanotechnology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
- Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
ORCID-Profile: Anayatollah Salimi
Zitieren
APA
Kaydan, H. H., Moghimipour, E., Dalvand, H., Jamali, N., Salimi, A., & Salimi, A. (2025). Design, Preparation, and Ex Vivo Skin Permeation of Doxepin Microemulsion System for Topical Delivery. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16786
Vancouver
Kaydan HH, Moghimipour E, Dalvand H, Jamali N, Salimi A, Salimi A. Design, Preparation, and Ex Vivo Skin Permeation of Doxepin Microemulsion System for Topical Delivery. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.16786
BibTeX
@article{Kaydan2025,
author = {Kaydan, Hossein Heidari and Moghimipour, Eskandar and Dalvand, Hossein and Jamali, Nasibeh and Salimi, Arghavan and Salimi, Anayatollah},
title = {Design, Preparation, and Ex Vivo Skin Permeation of Doxepin Microemulsion System for Topical Delivery},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.16786}
}
EUVIMED